| E-Y0001083 |
EP |
【甲基多巴系統(tǒng)適應(yīng) |
Methyldopa for system suitability |
|
0.024 mg |
1264 |
28 |
| E-Y0001082 |
EP |
【氟伐他汀系統(tǒng)適應(yīng) |
Fluvastatin for system suitability |
|
0.5 mg |
1264 |
28 |
| E-Y0001081 |
EP |
【甲芬那酸雜質(zhì)A（訂 |
Mefenamic acid impurity A |
|
100 mg |
1264 |
28 |
| E-Y0001080 |
EP |
【美洛昔康（訂貨以英 |
Meloxicam |
|
50 mg |
1264 |
28 |
| E-Y0001079 |
EP |
【芐絲肼峰值鑒別（訂 |
Benserazide for peak identification |
|
10 mg |
1264 |
28 |
| E-Y0001078 |
EP |
【比西酯試劑盒（訂貨 |
Bicisate labelling kit |
|
24 mg |
1264 |
28 |
| E-Y0001077 |
EP |
【碘普羅胺雜質(zhì)A（訂 |
Iopromide impurity A |
|
0.125 mg |
1264 |
28 |
| E-Y0001076 |
EP |
【氯沙坦系統(tǒng)適應(yīng)性 |
Losartan for system suitability |
|
0.0015 mg |
1264 |
28 |
| E-Y0001075 |
EP |
【利福昔明系統(tǒng)適應(yīng) |
Rifaximin for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0001074 |
EP |
【利福昔明（訂貨以英 |
Rifaximin |
|
160 mg |
1264 |
28 |
| E-Y0001073 |
EP |
【丙酸倍氯米松雜質(zhì) |
Beclometasone dipropionate impurities F and N |
|
0.052 mg |
1264 |
28 |
| E-Y0001072 |
EP |
【氯沙坦雜質(zhì)D（訂貨 |
Losartan impurity D |
|
10 mg |
1264 |
28 |
| E-Y0001071 |
EP |
【芐絲肼雜質(zhì)C（訂貨 |
Benserazide impurity C |
|
10 mg |
1264 |
28 |
| E-Y0001070 |
EP |
氨氯地平雜質(zhì)G |
Amlodipine impurity G |
|
10 mg |
1264 |
28 |
| E-Y0001069 |
EP |
【氨氯地平雜質(zhì)B（訂 |
Amlodipine impurity B |
|
15 mg |
1264 |
28 |
粵公網(wǎng)安備 44010302000979號(hào)
